Heading off depressive illness evolution and progression to treatment resistance

Dialogues in Clinical Neuroscience

Volumn 17, Issue 2, 2015, Pages 105-109

  Post, Robert M ^a,b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b Bipolar Collaborative Network   (United States)

Author keywords

Behavioral sensitization; Epigenetics; Kindling; Pharmacoprophylaxis; Stressor

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; DNA; LITHIUM; VASCULOTROPIN;

BIPOLAR DEPRESSION; CELL PROLIFERATION; COMORBIDITY; DEPRESSION; DISEASE COURSE; EDITORIAL; EPIGENETICS; HUMAN; MEMORY; NEUROBIOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; OXIDATIVE STRESS; PROPHYLAXIS; PUBLIC HEALTH; PUERPERAL DEPRESSION; RECURRENT DISEASE; RISK FACTOR; SENSITIZATION; STRESS; SUBSTANCE ABUSE; THERAPY RESISTANCE; ANIMAL; CHEMICALLY INDUCED; DEPRESSIVE DISORDER, TREATMENT-RESISTANT;

ANIMALS; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DISEASE PROGRESSION; EPIGENOMICS; HUMANS; RECURRENCE;

EID: 84940752089     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (47)

1. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry. 1992;149(8):999-1010.
2. Kessing LV, Andersen PK. Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? J Neurol Neurosurg Psychiatry. 2004;75(12):1662-1666.
3. Post RM. Preventing sensitization and kindling-like progression in the recurrent affective disorders. In: Chiccetti D, ed. Developmental Psychopathy. In press.
4. Post RM. The kindling/sensitization model and the pathophysiology of bipolar disorder. In: Soares J, Young A, eds. Bipolar Disorders: Basic Mechanisms and Therapeutic Implications. In press.
5. Kendler KS, Thornton LM, Gardner CO. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the "kindling" hypothesis. Am J Psychiatry. 2000;157(8):1243-1251.
6. Kendler KS, Thornton LM, Gardner CO. Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. Am J Psychiatry. 2001;158(4):582-586.
7. Slavich GM, Monroe SM, Gotlib IH. Early parental loss and depression history: associations with recent life stress in major depressive disorder. J Psychiatr Res. 2011;45(9):1146-1152.
8. Goddard GV, McIntyre DC, Leech CK. A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol. 1969;25(3):295-330.
9. Pinel JP. Effects of diazepam and diphenylhydantoin on elicited and spontaneous seizures in kindled rats: a double dissociation. Pharmacol Biochem Behav. 1983;18(1):61-63.
10. Antelman SM. Stressor-induced Sensitization to Subsequent Stress: Implications for the Development and Treatment of Clinical Disorders. Caldwell, NJ: Telford Press; 1988.
11. Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301(5631):386-389.
12. Kessing LV, Mortensen PB, Bolwig TG. Clinical definitions of sensitisation in affective disorder: a case register study of prevalence and prediction. J Affect Disord. 1998;47(1-3):31-39.
13. Post RM, Kalivas P. Bipolar disorder and substance misuse: pathological and therapeutic implications of their comorbidity and cross-sensitisation. Br J Psychiatry. 2013;202(3):172-176.
14. Covington HE, 3rd, Miczek KA. Repeated social-defeat stress, cocaine or morphine. Effects on behavioral sensitization and intravenous cocaine self-administration "binges". Psychopharmacology. 2001;158(4):388-398.
15. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(2):A42.
16. Newcomer JW, Hennekens CH. Severe mental illness and risk of cardiovascular disease. JAMA. 2007;298(15):1794-1796.
17. Nestler EJ. Epigenetic mechanisms of depression. JAMA Psychiatry. 2014;71(4):454-456.
18. Roth TL, Lubin FD, Funk AJ, Sweatt JD. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry. 2009;65(9):760-769.
19. Anier K, Zharkovsky A, Kalda A. S-adenosylmethionine modifies cocaine-induced DNA methylation and increases locomotor sensitization in mice. Int J Neuropsychopharmacol. 2013;16(9):2053-2066.
20. Krishnan V, Han MH, Graham DL, et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell. 2007;131(2):391-404.
21. Mitchell MR, Weiss VG, Beas BS, Morgan D, Bizon JL, Setlow B. Adolescent risk taking, cocaine self-administration, and striatal dopamine signaling. Neuropsychopharmacology. 2014;39(4):955-962.
22. Day JJ, Sweatt JD. Epigenetic mechanisms in cognition. Neuron. 2011;70(5):813-829.
23. Zovkic IB, Guzman-Karlsson MC, Sweatt JD. Epigenetic regulation of memory formation and maintenance. Learn Mem. 2013;20(2):61-74.
24. Mishkin M, Appenzeller T. The anatomy of memory. Scientific American. 1987;256(6):80-89.
25. McGowan PO, Sasaki A, D'Alessio AC, et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci. 2009;12(3):342-348.
26. Labonte B, Suderman M, Maussion G, et al. Genome-wide methylation changes in the brains of suicide completers. Am J Psychiatry. 2013;170(5):511-520.
27. Mehta D, Klengel T, Conneely KN, et al. Childhood maltreatment is associated with distinct genomic and epigenetic profiles in posttraumatic stress disorder. Proc Natl Acad Sci U S A. 2013;110(20):8302-8307.
28. McEwen BS. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology. 2000;22(2):108-124.
29. Kapczinski F, Vieta E, Andreazza AC, et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev. 2008;32(4):675-692.
30. Epel ES, Blackburn EH, Lin J, et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A. 2004;101(49):17312-17315.
31. Elvsashagen T, Vera E, Boen E, et al. The load of short telomeres is increased and associated with lifetime number of depressive episodes in bipolar II disorder. J Affect Disord. 2011;135(1-3):43-50.
32. Entringer S, Epel ES, Kumsta R, et al. Stress exposure in intrauterine life is associated with shorter telomere length in young adulthood. Proc Natl Acad Sci U S A. 2011;108(33):E513-518.
33. Wolkowitz OM, Mellon SH, Epel ES, et al. Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress--preliminary findings. PloS One. 2011;6(3):e17837.
34. Martinsson L, Wei Y, Xu D, et al. Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeres. Transl Psychiatry. 2013;3:e261.
35. Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet. 2003;361(9358):653-661.
36. Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry. 2003;160(8):1516-1518.
37. Wickramaratne P, Gameroff MJ, Pilowsky DJ, et al. Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study. Am J Psychiatry. 2011;168(6):593-602.
38. Bale TL. Lifetime stress experience: transgenerational epigenetics and germ cell programming. Dialogues Clin Neurosci. 2014;16(3):297-305.
39. Szutorisz H, DiNieri JA, Sweet E, et al. Parental THC exposure leads to compulsive heroin-seeking and altered striatal synaptic plasticity in the subsequent generation. Neuropsychopharmacology. 2014;39(6):1315-1323.
40. Weissman MM, Wickramaratne P, Nomura Y, et al. Families at high and low risk for depression: a 3-generation study. Arch Gen Psychiatry. 2005;62(1):29-36.
41. Lange KJ, McInnis MG. Studies of anticipation in bipolar affective disorder. CNS Spectr. 2002;7(3):196-202.
42. Post RM. Clinical staging in bipolar disorder: A historical perspective. In: Kapczinski F, ed. Staging in Bipolar Illness? Oxford, UK: Oxford University Press. In press.
43. Post RM, Fleming J, Kapczinski F. Neurobiological correlates of illness progression in the recurrent affective disorders. J Psychiatr Res. 2012;46(5):561-573.
44. Post RM, Altshuler L, Kupka R, et al. More pernicious course of bipolar disorder in the United States than in many European countries: implications for policy and treatment. J Affect Disord. 2014;160:27-33.
45. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Jr., Kinzler KW. Cancer genome landscapes. Science. 2013;339(6127):1546-1558.
46. Post RM. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neurosci Biobehav Rev. 2007;31(6):858-873.
47. Post RM. Animal models of mood disorders: Kindling as model of affective illness progression. In: Schachter SC, Trenite DG, eds. Behavioral Aspects of Epilepsy: Principles and Practice. New York, NY: Demos; 2008.